Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Fortune India
9m
AstraZeneca Pharma gets nod to sell immunotherapy drug Durvalumab; stock surges
This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.
Daily
48m
Lung cancer drug: AstraZeneca India wins CDSCO nod for Durvalumab for specified additional indication
Bengaluru: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Durvalumab 120 ...
53m
on MSN
AstraZeneca Pharma shares rally 13%, hit 52-week high after receiving nod for cancer drug Durvalumab
The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Left note, bail denied
1951 kidnap victim found
Didn't authorize apology
No govt. shutdown for now
Astronauts return to Earth
Tech ban proposed
Makes emergency landing
Economic speech this week
Closing last full-size store
Dolphins legend Morris dies
Visits US ammunition plant
Returning Indian antiquities
Gulf Coast storm warning
Reds fire manager
Co-founder testifies
More troops to Middle East
FBI: Violent crime declined
Bulls escape MA rodeo
California sues ExxonMobil
NE electoral change blocked
Colo. shooter found guilty
SpaceX plans Mars missions
NY reports death from EEE
1/3 think they have CTE
Friedkin set to buy Everton
Asks to be put on NY ballot
Texas sues Biden admin
Trump's Pennsylvania rally
Seeks NIL compensation
Feedback